Cargando…
A homogeneous split-luciferase assay for rapid and sensitive detection of anti-SARS CoV-2 antibodies
Better diagnostic tools are needed to combat the ongoing COVID-19 pandemic. Here, to meet this urgent demand, we report a homogeneous immunoassay to detect IgG antibodies against SARS-CoV-2. This serological assay, called SATiN, is based on a tri-part Nanoluciferase (tNLuc) approach, in which the sp...
Autores principales: | Yao, Zhong, Drecun, Luka, Aboualizadeh, Farzaneh, Kim, Sun Jin, Li, Zhijie, Wood, Heidi, Valcourt, Emelissa J., Manguiat, Kathy, Plenderleith, Simon, Yip, Lily, Li, Xinliu, Zhong, Zoe, Yue, Feng Yun, Closas, Tatiana, Snider, Jamie, Tomic, Jelena, Drews, Steven J., Drebot, Michael A., McGeer, Allison, Ostrowski, Mario, Mubareka, Samira, Rini, James M., Owen, Shawn, Stagljar, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985487/ https://www.ncbi.nlm.nih.gov/pubmed/33753733 http://dx.doi.org/10.1038/s41467-021-22102-6 |
Ejemplares similares
-
Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS‐CoV‐2
por: Mendoza, Emelissa J., et al.
Publicado: (2020) -
A simple protein-based surrogate neutralization assay for SARS-CoV-2
por: Abe, Kento T., et al.
Publicado: (2020) -
Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
por: Valcourt, Emelissa J., et al.
Publicado: (2021) -
B cell linker protein (BLNK) is a regulator of Met receptor signaling and trafficking in non-small cell lung cancer
por: Pathmanathan, Shivanthy, et al.
Publicado: (2022) -
Loss of repeat convalescent plasma donors due to waning anti-SARS-CoV-2 plaque reduction neutralization test titers (April-December 2020)
por: Drews, Steven, et al.
Publicado: (2022)